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The identification of HIV-1-infected individuals who remain asymptomatic despite prolonged infection presents a unique
opportunity to understand virologic and host factors involved in the pathogenesis of AIDS. We have previously identified
10 long-term survivors (LTS) who are clinically healthy and immunologically normal despite 13 to 15 years of HIV-1 infection.
In this study, we examined three accessory genes of HIV-1, vif, vpr, and vpu, in these LTS. A total of 52 vif, 54 vpr, and 55
vpu nucleotide sequences were obtained from the peripheral blood mononuclear cells of these patients. Analysis of these
sequences revealed no gross deletions or insertions. Most of the clones were full-length with an intact open reading frame.
Phylogenetic analyses of the vif, vpr, and vpu sequences from the LTS suggested that the HIV-1 strains found in the study
subjects are not significantly different from those found in patients with AIDS and that the viruses in the LTS are unlikely
to share a common genetic origin. Furthermore, a similar degree of overall genetic diversity between viruses from the LTS
and AIDS patients suggests that there is unlikely a significant correlation between the degree of genetic diversity and the
rate of disease development. Factors other than genetic divergence, such as viral load and phenotype, are likely to impact
more on disease status. q 1997 Academic Press
INTRODUCTION (LTS) are relatively robust compared to responses in
progressors (Cao et al., 1995; Iversen et al., 1995; Rinaldo
Human immunodeficiency virus type 1 (HIV-1) infection et al., 1995). Plasma samples from LTS had broad neu-
causes progressive damage to the immune system tralizing activity against both primary and laboratory-
which, in most cases, will eventually lead to opportunistic adapted HIV-1, which contrasted greatly with that from
infections, malignancies, or a wasting syndrome that subjects with progressive disease (Cao et al., 1995). High
constitute clinically defined AIDS. The median time from level of HIV-1-suppressive response by CD8/ lympho-
the onset of infection to AIDS is approximately 8–10 cytes was also found in LTS (Cao et al., 1995; Lifson et
years (Buchbinder et al., 1993; Levy, 1993; Schrager et al., al., 1991; Rinaldo et al., 1995). There is also evidence
1994), although some rapid progressors develop AIDS in that virus strains in some LTS may be attenuated. For
as little as 2–4 months (Isaksson et al., 1988; McLean example, some isolates from our cohort of LTS tend to
et al., 1990). A unique group of infected individuals, replicate slowly in vitro (Cao et al., 1995), and genetic
known as long-term survivors (LTS), has been identified defects have been reported in some viruses infecting
from several cohort studies (Bacchetti and Moss, 1989; LTS in other cohorts (Deacon et al., 1995; Iversen et al.,
Buchbinder et al., 1993; Cao et al., 1995; Learmont et al., 1995; Kirchhoff et al., 1995; Learmont et al., 1992). In
1992). These patients, despite being infected for at least particular, nef defects were found in all viruses se-
10 years, remain clinically healthy without appreciable quenced from one LTS, as well as from a group of epide-
declines in CD4/ cell counts (Bacchetti and Moss, 1989;
miologically linked blood recipients (Deacon et al., 1995;
Buchbinder et al., 1993; Cao et al., 1995; Learmont et al.,
Kirchhoff et al., 1995). Other accessory genes, such as
1992; Lifson et al., 1991). While it is possible that this
vif, vpr, vpu, and rev were also shown to be defective in
group of patients lies at the tail end of a normal distribu-
some of the LTS (Iversen et al., 1995; Michael et al.,
tion curve that describes the variable time it takes to
1995). Taken together, these data suggest that multiple
develop AIDS, recent studies provide evidence to the
factors contribute to the prolonged, asymptomatic infec-
contrary (Cao et al., 1995; Deacon et al., 1995; Iversen
tion in LTS. Extensive studies of HIV-1 as well as the
et al., 1995; Kirchhoff et al., 1995; Michael et al., 1995).
infected hosts will help to dissect out the factors respon-We and others have previously shown that the humoral
sible for the attenuated clinical course.and cellular immune responses in long-term survivors
We previously studied the nef genes from our cohort
of LTS, both genotypically and phenotypically, and found
that the nef sequence and function were intact (Huang1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (212) 725-1126. E-mail: dho@adarc.org. et al., 1995a, 1995b). Thus, defects in nef are unlikely to
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be the underlying explanation for the long-term survival cell counts despite 13 to 15 years of HIV-1 infection.
Unfortunately patient 1 (Pt 1) was lost to follow up. Theof our cohort. The functional properties of env genes from
our cohort of LTS were also studied. Envelope glycopro- clinical profile for the rest of the nine LTS is summarized
in Table 1.teins from four members of the cohort have been shown
to be poorly processed and failed to mediate infection
in pseudotyped HIV-1 virion, suggesting functional ab- Samples
normalities in these Env glycoproteins (Connor et al.,
1996). In the current study, we examined three other PBMC were isolated from each subject by centrifuga-
tion of blood through a Ficoll-Hypaque density gradientaccessory genes of HIV-1, vif, vpr, and vpu, in the same
cohort of LTS to further explore the possibility that spe- (Pharmacia). Genomic DNA was then extracted, using a
standard proteinase K/phenol protocol (Maniatis et al.,cific viral defects account for the long-term survival of
these subjects. 1982). Negative controls were included throughout the
entire extraction procedure to monitor the possibilitiesVif, a 23-kDa nonstructural protein found in almost all
primate and nonprimate lentiviruses, is essential for in- of cross contamination.
fectivity of HIV-1 in both cell-free and cell-to-cell trans-
mission (Sakai et al., 1991; Trono, 1995; von Schwedler PCR amplification of viral vif, vpr, and vpu sequences
et al., 1993). The Vif requirement for viral infectivity, how-
ever, is strictly mediated in the virus-producing cell rather Nested PCR was used to amplify viral sequences due
to the genuine low copy numbers in the infected cellsthan in the target cell (Trono, 1995; von Schwedler et al.,
1993). (Cao et al., 1995; Huang et al., 1995a). For each sample,
approximately 1 mg of genomic DNA was used. BothVpr is unique among the accessory gene products in
that it associates with the mature viral particle (Cohen rounds of PCR consisted of 30 cycles, with each cycle
involving three steps: 1 min at 947 for denaturation, 1 minet al., 1990), through an interaction with the Gag protein
p6 (Paxton et al., 1993). This interaction is believed to be at 557 for annealing, and 2 min at 727 for elongation. A
final extension of 7 min at 727 was performed at the endcritical for HIV-1 infection of quiescent cells and macro-
phages (Connor et al., 1995; Heinzinger et al., 1994), pos- of the 30 cycles. A polymerase (Pfu, Stratagene) with
proofreading activity was used in conjunction with Taqsibly by facilitating the nuclear transport of the preinte-
gration complex (Heinzinger et al., 1994). More recent (Boehringer Mannheim) polymerase to improve the accu-
racy of the amplification, while maintaining the high pro-studies have shown that Vpr plays a key role in the inter-
action between HIV-1 and the infected target cell. Specifi- cessivity of Taq. The nucleotide sequences of the outer
(a, b) and inner (c, d) primer pairs for HIV-1 are listedcally, Vpr has been shown to arrest cells in the G2 phase
(Levy et al., 1993; Rogel et al., 1995), an effect likely to below; the coordinates shown in parentheses denote
their positions in the HIVNL43 sequence (/, sense andbe mediated by the arginine-rich region at the carboxyl
terminus of Vpr (di Marzio et al., 1996; He et al., 1995). 0, antisense): a, 5*-TTAAAAGAAAAGGGGGGATTGG-
GGG (/, 4785); b, 5*-ATTCCATGTGTACATTGTACTGTUnlike Vif and Vpr, Vpu is only present in HIV-1 and
SIVcpz (Huet et al., 1990). Although not essential for viral (0, 6953); c, 5*-AGATAATAGTGACATAAAAGTAGTGCC-
AAGAAG (/, 4985); and d, 5*-CCATAATAGACTGTGACC-replication in vitro, the expression of Vpu has been dem-
onstrated to enhance virion release and the degradation CACAA (0, 6325).
of CD4 in the endoplasmic reticulum (Klimkait et al., 1990;
Lenburg and Landau, 1993). Phosphorylation of two ser- Cloning, sequencing, and sequence analysis
ine residues at positions 53 and 57 is absolutely required
for its CD4-degradation property, but is not essential for The PCR products of vif, vpr, and vpu were ligated
directly to a prokaryotic TA vector (Invitrogen). Clonedits enhancement of virion release, suggesting a dual
function for Vpu (Bour et al., 1995; Schubert et al., 1996; PCR products were sequenced using the Sequenase kit
(United States Biochemical). Nucleotide sequence wereSchubert and Strebel, 1994). Vpu enhances the release
not only of HIV-1 particles, but also of HIV-2, SIV, and aligned with the Clustal V program, which was kindly
provided by D. G. Higgins (Higgins and Sharp, 1989). Nomurine leukemia virus (Goettlinger et al., 1993). The
structural similarity between Vpu and an ion channel gaps were included in the following analysis. Genetic
distances between pairs of sequences were estimatedprotein, M2 of the influenza virus, might provide a clue
as to the mechanism that Vpu utilizes to induce virion with the DNADIST program implemented in the PHYLIP
package (version 3.5) (Felsenstein, 1988). Phylogeneticrelease (Trono, 1995).
trees were constructed with several algorithms, including
MATERIALS AND METHODS
neighbor joining and parsimony. Similar phylogenetic re-
Study subjects lationships were also found in 1000 bootstrap replicates
of neighbor-joining trees (PHYLIP programs SEQBOOTTen long-term survivors were previously chosen on
the basis of their asymptomatic status and normal CD4 and CONSENSE.
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TABLE 1a
Characteristics of Long-Term Survivors of HIV-1 Infection
Isolation of HIV-1 from
Route of Duration of CD4 cell count
Subject Age (years)/sex infection infection (years) (no./mm3) PBMC Plasma
Pt2 38/M IV drug use ⁄12 500–700 0 0
Pt3 46/M Homosexual ⁄13 560–740 0 0
Pt4 40/M Homosexual 14 500–1200 0 0
Pt5 41/M IV drug use ⁄12 800–1000 0 0
Pt6 38/M Homosexual 12 560–860 0 0
Pt7 42/F Heterosexual 13 500–850 /b 0
Pt8 44/M Homosexual ⁄15 400–800 / 0
Pt9 47/M Homosexual 14 600–1100 / 0
Pt10 47/M Homosexual ⁄14 550–850 / 0
a This table has been presented previously elsewhere (Huang et al., 1995a) and is included here solely for clarity.
b By CD8 depletion only.
RESULTS to the range found in patients with more standard
courses of infection (Sova et al., 1995; Wieland et al.,
Length polymorphism and nucleotide sequence 1994). In addition, a six nucleotide in-frame deletion was
variation in vif, vpr, and vpu found in all of the vpu clones in Pt 5 and two vpu clones
in Pt 10 (Pt 10-4 and Pt 10-6, see Fig. 1c). The nucleotideDNA was extracted from the PBMC of the nine LTS,
sequences have been deposited in GenBank, and theirand sequences spanning vif, vpr, and vpu were amplified
accession numbers are pending.by PCR. All nine subjects yielded positive signal. The
length of the amplified PCR products was approximately Features of deduced Vif, Vpr, and Vpu amino acid
the same as that of HIVNL43 (data not shown), sug- sequences from LTS
gesting that there were no gross deletions or insertions
in any of the study subjects. Within each sample, the Nucleotide sequences from the nine PCR-positive LTS
were translated and aligned. They are shown in Figs.PCR products appeared homogeneous in length as re-
flected by a single, sharp band on the gel (data not 1a, 1b, and 1c together with selected sequences from
patients with AIDS. Inspection of deduced Vif aminoshown). In multiple, independent PCR amplifications
these findings remained consistent. Initially, efforts had acids from our group of LTS and from patients with AIDS
(Fig. 1a) revealed a considerable degree of variationalso been made to use RT/PCR to amplify viral RNA
sequences from the collected plasma samples. But due across the entire protein. A high frequency of amino acid
replacements occurred in two regions, between aminoto the low viral loads in these individuals, the attempts
failed despite repeated efforts. acids 27 and 50 and between 85 and 167, with the 5*, 3*,
and intervening regions remaining relatively conserved.The homogeneity in the length of vif, vpr, and vpu was
also confirmed by sequence analysis. A total of 52 vif, While specific functional domains of Vif have yet to be
identified, two cysteine residues at positions 114 and54 vpr, and 55 vpu sequences was obtained from the
nine PCR-positive samples. Inspection of these nucleo- 133 have been shown to be critical for Vif function (Ma
et al., 1994). Two highly conserved amino acid motifs,tide sequences revealed no obvious length polymor-
phism, with almost all of the clones being similar in SL(I/V)X4YX9Y and SLQXLA, located between amino
acids 23 and 40, and 144 and 149, respectively, werelength to HIVNL43. Nevertheless, a point deletion re-
sulting in a frameshift was found in three vif clones (Pt identified based on 38 lentivirus Vif sequences (Oberste
and Gonda, 1992). These highly conserved amino acid7-2, Pt 4-10, Pt 4-11) (Fig. 1a), two vpr clones (Pt 7-9, Pt
8-1) (Fig. 1b), and two vpu clones (Pt 7-11, Pt 8-6) (Fig. residues and motifs were found to be invariant in most
of the LTS Vif sequences, although a few changes have1c). The average defective frequencies were, therefore,
5.8% in vif, 3.8% in vpr, and 3.6% in vpu, which are close been observed in Pt 6 and Pt 4. The hydrophilic region
FIG. 1. Alignment of the Vif, Vpr, and Vpu protein sequences derived from LTS, in conjunction with some isolate sequences from patients with
AIDS. The deduced amino acid sequences are aligned using the single-letter code against HIVNL43, and their positions are indicated (underlined)
according to HIVNL43 sequence. Dots represent identical residue sequences; asterisks represent stop codons. The location of putative domains
are shown above sequence of HIVNL43. The cysteine residues of Vif at positions 114 and 133, previously shown critical for Vif function, and the
two serine residues of Vpu at positions 53 and 57, the targets for kinase phosphorylation, are indicated by arrows.
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FIG. 1—Continued
between positions 87 and 94 (IEWRKKRY), previously at position 76, were all well conserved among the LTS
sequences (N. R. Landau, personal communication) (Fig.shown to be antigenic (Wieland et al., 1994), was also
relatively conserved among the LTS in terms of its amino 1b). Residues located between positions 29 and 36, pre-
viously shown to be critical for Vpr packaging into virions,acid composition, as most of the changes observed in
this region were restricted to positively charged residues were invariant in all of the clones sequenced (di Marzio et
al., 1996). In addition, examination of the region betweensuch as changes from lysine (K) to arginine (R) or vice
versa (Fig. 1a). positions 17 and 34, predicted to form an alpha-helix in
the native protein (di Marzio et al., 1996), revealed noAs for the Vpr protein sequences from this group of
LTS (Fig. 1b), what is striking is not the degree of diversity changes that would disrupt the putative alpha-helical
structure. The recently discovered cell-cycle arrest activ-but rather the degree of conservation across the entire
protein. Previously identified invariant residues, such as ity of Vpr has prompted many investigators to map the
region(s) responsible for this effect; the region betweenglutamic acid (E) at position 2, tryptophan (W) at position
18, histidine (H) at positions 33 and 78, and cysteine (C) residues 85 and 95 is believed to play a major role (di
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FIG. 1—Continued
Marzio et al., 1996). Inspection of those amino acid resi- Figure 1c shows the aligned amino acid sequences
of Vpu from the nine PCR-positive LTS, along with somedues from the LTS reveals some degree of variation (Fig.
1b). In particular, sequence variation has been observed selected sequences from patients with AIDS. Examina-
tion of these sequences reveals that most Vpu se-at position 89, involving frequent replacement of alanine
(A) by threonine (T) in Pt 4, Pt 6, Pt 7, Pt 9, and Pt 10, or quences in the LTS are full-length with an intact open
reading frame. While our understanding of Vpu functionof alanine (A) by serine (S) in Pt 3. Other replacements
within this region were also observed, such as an alanine is incomplete, recent studies have shown that Vpu can
enhance virus release as well as degrade CD4 in the ER(A) to serine (S) change at position 93 in patient Pt 10,
and glutamine (Q) and alanine (A) changes to positively (Klimkait et al., 1990; Lenburg and Landau, 1993; Schu-
bert et al., 1996; Schubert and Strebel, 1994). Degradationcharged arginines (R) at positions 86 and 93, respec-
tively, in Pt 7. The biological significance of these varia- of CD4 by Vpu is likely to be a multistep process, includ-
ing at least two separate events of binding and degrada-tions warrants further studies.
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TABLE 2 The degree of intrasubject sequence diversity of each
gene within each LTS varied substantially from case toComparison of Genetic Divergence of vif, vpr, and vpu Sequences
case. In Pt 7, the degree of diversity for three genes iswithin and between the LTS and AIDS Patients
as high as 2.8 to 3.2%, whereas in Pt 5 it can be as low
Divergencea as 0.1 to 0.2% (Table 2). The mean intersubject diversity
of each gene, however, was approximately 20 times
vif vpr vpu
higher than the mean intrasubject diversity. The degrees
of intersubject sequence diversity among all of the LTSIntra-
Pt2 0.0031 0.0041 0.0023 were 5.5% for vif, 5.9% for vpr, and 8.8% for vpu, which
Pt3 0.0087 0.0069 0.0046 are not significantly different from those determined from
Pt4 0.0224 0.0224 0.0104 AIDS patients (P 0.01). The overall degree of sequence
Pt5 0.0017 0.0017 0.0021
variation in vif, vpr, and vpu is, therefore, not likely associ-Pt6 0.0077 0.0079 0.0090
ated with disease progression during the course of HIV-Pt7 0.0289 0.0328 0.0280
Pt8 0.0141 0.0190 0.0323 1 infection. This conclusion is consistent with previous
Pt9 0.0096 0.0098 0.0068 reports (Goodnow et al., 1989; Huang et al., 1995b; Leigh
Pt10 0.0105 0.0046 0.0257 Brown, 1991; McNeary et al., 1992).
Inter-
LTS 0.0547 0.0585 0.0880 Phylogenetic relationship of vif, vpr, and vpu
AIDSb 0.0579 0.0463 0.1230 sequences
a Calculated by program DNADIST, implemented in the PHYLIP pack- The phylogenetic relationship between the sequences
age (Felsenstein, 1988). obtained from the LTS was determined and compared
b Isolate sequences of AIDS patients used in this study were ob- with sequences from AIDS patients. Figure 2 depicts un-
tained from Los Alamos database. These sequences include HIVMN , rooted neighbor-joining trees based on the sequencesHIVJRCSF , HIVJRFL , HIVRF , HIVHAN , HIVYU2 , and HIVNL43 .
obtained for vif, vpr, and vpu. Nucleotide sequences for
vif, vpr, and vpu from the LTS interdigitated with those
tion (Schubert et al., 1996; Schubert and Strebel, 1994).
from AIDS patients, without apparent grouping among
The domain in Vpu that may potentially bind to the cyto-
themselves. In Fig. 2, for example, vif sequences from Pt
plasmic tail of CD4 is believed to involve two putative,
2 were more similar to sequences (HIVJRFL, HIVJRCSF)
amphipathic alpha-helical domains located between
from a patient with AIDS than to those from other LTS,
amino acid residues 30 and 50, and 59 and 76 (Schubert
such as Pt 3 or Pt 4. Similarly, vpr sequences from Pt 6
and Strebel, 1994). Analysis of Vpu sequences from most
were genetically closer to HIVMN than to any of the other
of the LTS studied here revealed that sequence variation
LTS vpr sequences (Fig. 2). Another feature of the vif, vpr,
in these two domains was minor, especially within the
and vpu sequences from our group of LTS was the tight
second domain spanning positions 59 to 76 (Fig. 1c). In
grouping of sequences within each subject without evi-
the first domain, amino acid changes from leucine (L) to
dent clustering of sequences from different individuals.
isoleucine (I) at position 42 were observed in Pt 4 and
Similar observations have also been made for the nef
Pt 6, whereas changes from aspartic acid (D) to alanine
sequences in our previous report (Huang et al., 1995a).
(A) at position 43 were found in Pt 8 (Fig. 1c). However,
Taken together, the data strongly indicate that the nucleo-
two serine residues localized between the two alpha-
tide sequences from the LTS studied here are indistin-
helixes at positions 53 and 57 were well conserved
guishable from those in AIDS patients and that there is
among all the sequences studied. Phosphorylation of
no common genetic origin for the viruses in these LTS.
Vpu at these two serine residues has previously been
shown to be essential for Vpu-dependent CD4 degrada-
DISCUSSIONtion (Schubert and Strebel, 1994). Conservation of the
binding and phosphorylation sites in the Vpu sequences Substantial variation in the rate of disease progression
from most of the LTS suggests that, as shown for Vif has been observed among patients infected with HIV-1.
and Vpr, an intact Vpu has strongly been selected for in In most cases, the infected individual has an extended
majority of LTS. asymptomatic period prior to the development of AIDS,
whereas some become immunosuppressed and develop
Genetic diversity of vif, vpr, and vpu in LTS opportunistic complications rapidly (Isaksson et al., 1988;
McLean et al., 1990). It has become evident recently fromTo further delineate the genetic features of vif, vpr,
and vpu from our group of LTS, the degree of sequence several cohort studies that a small proportion (approxi-
mately 5 to 8%) of infected individuals has remained clini-diversity was analyzed and compared with some pub-
lished sequences (HIVMN, HIVJRCSF, HIVJRFL, HIVRF, cally healthy and without evidence of immunodeficiency
despite prolonged infection. These individuals are there-HIVHAN, HIVYU2, HIVNL43) from AIDS patients, using
Kimura’s two parameter model (Kimura, 1988) (Table 2). fore called LTS or long-term nonprogressors.
AID VY 8378 / 6a28$$$183 01-21-97 11:21:03 vira AP: Virology
347GENETIC CHARACTERIZATION OF vif, vpr, AND vpu SEQUENCES
FIG. 2. Unrooted neighbor-joining tree depicting evolutionary relationship among vif, vpr, and vpu nucleotide sequences from both LTS and
patients with AIDS. Individual sequences from LTS are represented by their code at the ends of branches, which are drawn to scale so that the
relatedness between different sequences can be readily assessed. For each individual, only a minimal number of sequences are shown in the tree
for clarity of presentation. Isolate sequences from AIDS patients are highlighted. The bootstrap values that are higher than 95% are indicated on
the branches.
We have previously identified 10 LTS and found that son et al., 1996). There is also ample evidence to stress
the importance of viral load and phenotype in influencingthe humoral and cellular immune responses in these LTS
are relatively robust compared to responses in prog- disease progression (Mellors et al., 1996; O’Brien et al.,
1996). In particular, nef defects were found in all virusesressors (Cao et al., 1995). Plasma samples from LTS
had broad neutralizing activity against both primary and sequenced from one LTS (Kirchhoff et al., 1995), as well
as from a group of epidemiologically linked blood recipi-laboratory-adapted HIV-1, which contrasted greatly with
that from subjects with progressive disease (Cao et al., ents who have also remained clinically well and immuno-
logically stable despite a decade of infection (Deacon et1995). High levels of HIV-1-suppressive response by
CD8/ lymphocytes was also found in LTS (Cao et al., al., 1995).
In this study, we examined three accessory genes of1995; Iversen et al., 1995; Lifson et al., 1991; Rinaldo et
al., 1995). A vigorous virus-specific immune response HIV-1, vif, vpr, and vpu, in the same cohort of LTS to
further explore the possibility that specific viral defectstherefore contributes, at least in part, to the prolonged
and attenuated course of HIV-1 infection in LTS. The nef account for the long-term survival of these subjects. Our
results suggest the following conclusions. First, majoritygenes from our cohort of LTS were also studied both
genotypically and phenotypically. We found that the nef of HIV-1 sequences found in LTS were full-length with
an intact open reading frame, suggesting that geneticsequence and function were intact, suggesting that de-
fects in nef are unlikely to be the underlying explanation defects in vif, vpr, and vpu are unlikely to be the underly-
ing explanation for the well-being of our cohort of LTS.for the long-term survival of our cohort (Huang et al.,
1995a, 1995b). Second, the HIV-1 strains found in the LTS are not signifi-
cantly different from those found in AIDS patients, andMultiple factors, including host, immune, and viral, are
believed to be involved in governing the rate of disease the viruses in the LTS are unlikely to share a common
genetic origin. Third, a similar degree of overall geneticprogression of HIV-1-infected patients. The clinical se-
quela of each infection is therefore dependent on the diversity between viruses from the LTS and AIDS patients
suggests that there is unlikely a significant correlationfine balance of these multifactorial interactions. It would
be unlikely to have a common universal explanation for between the degree of genetic diversity and the rate of
disease development. Factors that contribute to the long-all of the LTS. Some host factors such as HLA type has
been suggested to confer a differential susceptibility to term survival of HIV-1 infection therefore await further
investigations.HIV-1 infection and its pathogenic effects (Kaslow et al.,
1990; Williams and Cloyd, 1991). The genotypic feature
of secondary receptor for primary HIV-1 infection, b- ACKNOWLEDGMENTS
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